CULVER CITY, Calif.--(BUSINESS WIRE)--ImmunityBio, Inc. (NASDAQ: IBRX), a leading immunotherapy company, today announced new paradigm changing findings from the Phase 2 QUILT-3.055 study, ...

Patients diagnosed with recurrent or progressive extensive-stage small cell lung cancer (ES-SCLC) may benefit from treatment with ifinatamab deruxtecan (I-DXd), a B7-H3–directed antibody–drug ...

(Barcelona, Spain. September 7, 2025 at 4:45 PM CEST / UTC +2 )--Patients diagnosed with recurrent or progressive extensive-stage small cell lung cancer (ES-SCLC) may benefit from treatment with ...

Researchers at MUSC Hollings Cancer Center have discovered a potentially powerful weapon in the fight against head and neck cancers. The new drug, still in preclinical studies, attacks cancer cells ...

Gordon Ramsay is serving up a serious health warning. The celebrity chef revealed he recently had a basal cell carcinoma removed and shared a photo of the scar with his 19.2 million Instagram ...

The celebrity chef spoke candidly about his cancer scare in an Instagram post on Saturday, Aug. 30 Andrew Chin/Getty; Gordon Ramsay/Instagram Gordon Ramsay announced that he underwent treatment for ...

Aug 21 (Reuters) - Gilead Sciences' (GILD.O), opens new tab unit Kite Pharma said on Thursday it will acquire privately-held biotech firm Interius BioTherapeutics for $350 million in cash to advance ...

Data from IDeate-Lung01 trial will be presented at upcoming IASLC 2025 World Conference on Lung Cancer First Breakthrough Therapy Designation for Daiichi Sankyo and Merck’s ifinatamab deruxtecan based ...

Amid the "highs and lows" of her cancer battle, Teddi Mellencamp is seeing a bright future. Asked about her prognosis on the July 29 episode of "The Jamie Kern Lima Show," the 44-year-old daughter of ...

A UCSF and Gladstone Institutes team discovered a pair of cancer drugs that successfully treated a model of severe Alzheimer’s disease. From left: Marina Sirota, PhD; Yaqiao Li, PhD; and Yadong Huang, ...